Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124988) titled 'An Open-label, Multicenter Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of JH021 Injection in Patients With Advanced Solid Tumors' on May 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai East Hospital
Condition:
advanced solid tumor
Intervention:
Phase ?a: Dose Escalation Study
:Explore dosage ranges of 150mg, 450mg, 900mg, 1400mg, 1800mg, totaling 5 dosage levels, JH021 injection
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-05-31
Target Sample Size: Phase ?a: Dose Esc...